# Stage 11 Independent Critic Review

- **Date**: 2026-07-18
- **Reviewer**: independent critic pass, run by a separate agent from the primary executor (per `CRITIC.md` / D-003 operating model)
- **Stage under review**: 11 — Commercial & Product Strategy (executor pass committed at `e847160`)

---

## Verdict

**PASS** — zero required corrections. No blocking human decision remains for stage closure.

---

## Scope reviewed

- Contract and standards: `CRITIC.md`, `POLICY.md`, `RUNBOOK.md`, `_core/EVIDENCE-STANDARD.md`, `_core/FINDING-SCHEMA.md`, `_core/SEVERITY-MODEL.md`.
- The full stage: `CONTEXT.md`, `findings.md` (F-11-01, F-11-02), `decisions.md` (DEC-11-01..08), `evidence/11-business-context-excerpts.md`, and all 7 outputs (`commercial-value-map.md`, `sequencing-economics.md`, `product-scope-boundaries.md`, `positioning-and-claims.md`, `pre-build-decision-logistics.md`, `stage-12-handoff.md`, `stage-13-handoff.md`).
- Binding inputs re-read at source: Stage 09 and Stage 10 `stage-11-handoff.md`; `residual-risk-register.md` (RR-1..5, trigger (c), DEC-10-16 boundary); `launch-gate-evidence-register.md` (incl. §5 and the CG-11/CG-12 human-decision rows); `calibration-governance.md` §2; `evidence-chain-and-baselines.md` Part B; `standing-assurance-controls.md` §6; Stage 04 `outcome-prioritisation.md`, `measurement-framework.md`, `findings.md` (F-04-01/06 + forwarding list), `stage-11-handoff.md`; Stage 05 `capability-readiness-matrix.md`; Stage 02 `non-negotiable-product-principles.md` (Principle 8); Stage 06 `compliance-monitoring-source-policy.md` §§4–5, `statutory-change-control-design.md` §8, `agent-tool-audit-standard.md` §2; Stage 10 `findings.md` (F-10-01/02); `_core/HUMAN-DECISIONS.md` (HD-6) and `03-agent-portfolio/stage-03-review-decision-prompt.md` (conditions 9–14).
- Programme state: `decision-queue.md`, `review-state.md`, `state.md`, `_inputs/source-register.md` (S-10), `git show --stat e847160`, working-tree status.
- Independent live reads outside the repo: `Clients/Sandy/_PRODUCT/EP-004_phase2-agentic/FEAT-021_saas-multi-tenant_FUTURE.md`, `FEAT-020_ai-payroll-engine_FUTURE.md`, `Clients/Sandy/CLAUDE.md`.

## Independent verification performed (not taken on the executor's word)

1. **F-11-01 evidence reproduced**: I read FEAT-021, FEAT-020, and `Clients/Sandy/CLAUDE.md` directly on 2026-07-18. The excerpts in `evidence/11-business-context-excerpts.md` §§1–3 are verbatim-accurate (FEAT-021: "Acceptance criteria: TBD — to be scoped after Phase 1 closure", Status FUTURE, "Sprint(s): Not yet started"; CLAUDE.md: "Phase 2 (future): Agentic SaaS payroll platform… Broader market"). F-11-01's current-implementation, intended-design, and gap claims all hold; RR-1 trigger (c) is armed exactly as the finding states (`residual-risk-register.md` §1 row RR-1, §3 boundary paragraph).
2. **F-11-02 absence claim spot-checked**: I swept `_inputs/source-register.md` (S-01–S-10 — no type-5 entries, no external commercial sources), `_core/HUMAN-DECISIONS.md` (all HD entries are review-scope/portfolio/calibration decisions — none is a demand statement), and grep-swept every stage `decisions.md` for demand/willingness-to-pay/client-request statements: zero hits. The absence finding is correct.
3. **Sequencing-economics traceability — 10+ constraints verified against source**: O1 (Stage 05 matrix: "Zero auth mechanism exists anywhere", C1 blocks everything); O2 (matrix C2/C3 rows); O3 (condition 12 — see observation 1 below); O4/O5/O6 (register §5: "C7-after-C2, C13-after-C14, C11-with-C12 … enforced as row-closure preconditions"; CG-7/CG-11/CG-13 rows); O8 (CG-11 "DQ-006 resolved pre-build … register row cannot close without it"; CG-12 "DQ-007 resolved pre-build"); O9 (agent-tool-audit-standard §2: DQ-008, keep-at-least-7y floor, no deletion mechanism; SC-4); W1 (calibration-governance §2 DEC-10-08: 3 full cycles AND ≥20 terminal records, both conditions); W2 (Stage 10 handoff §2.2 "unrecoverable … permanently anchorless"; evidence-chain B §2 B2 "requires a real onboarding — it cannot be synthesized"); W3/W4 (B6 4-week tally; B4 3-cycle window — verbatim in evidence-chain B §2); W5 (B §3: B3/B5 retrospectives "capturable immediately … de-risk two launch gates early"); W6 (statutory-change-control-design §8; source-policy §4). One-off costs: F-10-01 verified at source (~18 of 25 behaviours to scripted-manual, behaviour 21 permanently unprotected, harness with C1); platform-level area (Stage 09 handoff §3); cadence cap (standing-assurance-controls §6: "one monthly session … one quarterly session … the deliberate ceiling"). All trace accurately; none is weakened or embellished.
4. **DQ-005 disposition verified**: (a) Stage 09's §1 recommendation is represented faithfully in `product-scope-boundaries.md` §1 (contextual "Create correction run" CTA with/after C12, no generic dropdown, API-only persists deliberately, queue stays open until Stage 11 disposes); (b) the stage CONTEXT genuinely grants closure authority ("DQ-005 is the one queue item this stage co-owns and may close, if concurring…"); (c) the `decision-queue.md` DQ-005 row is consistent (resolved 2026-07-18, implementation-specification bound to C12, DEC-11-02 cited). The commercial half of the joint test is reasoned from the registered evidence base (no demand evidence, API path retained, guardrail-posture coherence) — a legitimate concurrence, not a rubber stamp.
5. **RR-1 trigger (c) handling verified**: the stage proposes no multi-tenant SaaS anywhere in the 7 outputs; the trigger check is explicit (DEC-11-04, `product-scope-boundaries.md` §2.2 bold statement); the DEC-10-16 boundary is quoted in its own terms and not absorbed or weakened — the SaaS question is forwarded as a three-part human bundle with RR-1 re-open named as part (b). Correct handling.
6. **No gate/disposition weakened**: C4/C8/C9/C15 stay non-value rows with their conditions intact; D-02-01..04, D-03-01 + conditions, D-04-01 and the measurement-framework prohibitions (usage volume never success; precision never volume; dry-run ≠ validated — all verified verbatim in `measurement-framework.md`) are restated as hard boundaries in the overclaim table, not diluted. The FULL_RUN fix is correctly carried as a handoff item outside programme write authority, not executed.
7. **Business-fact discipline**: grep sweep of the outputs for client-want/market-size/pricing/competitor-capability assertions found none of the invented-fact class. Every value claim is labelled operational-outcome inference or documented intent (type 4); the two genuinely missing facts are recorded as EG-004/EG-005 rather than assumed. "DIF = claimable, never demand-verified" is stated in the value map, the positioning doc (§5), both handoffs, and F-11-02 — the discipline is consistent, not decorative.
8. **Write containment and state consistency**: `git show --stat e847160` shows all 15 touched files inside `docs/programmes/agentic-architecture-review/`; working tree clean. `review-state.md` Stage 11 row, `state.md`, `CONTEXT.md` status, `decisions.md`, and the two handoffs are mutually consistent with the outputs and with each other.

---

## Strengths

1. **The absence finding (F-11-02) is the stage's best work.** The largest failure mode this stage was exposed to — inventing demand to make the strategy feel grounded — is not just avoided but converted into a confirmed, citable finding with a dated absence sweep, two queue-registered evidence gaps, and a downstream reading rule ("DIF means claimable, not market-verified"). Stage 12 cannot now drift into demand-led language without visibly contradicting a confirmed finding.
2. **Sequencing economics is a genuine consolidation, not a restatement.** Every O/W row carries a binding source that checks out; the calendar-bound items (especially W2's unrecoverable B1/B2 window) are correctly promoted from footnotes in Stage 10's handoff to first-class constraints, and the near-term actions list (§5) turns them into schedulable items without crossing into roadmap territory.
3. **Boundary discipline on the SaaS question.** The stage sat directly on top of the strongest temptation in the programme — the documented SaaS ambition — and handled it exactly per contract: trigger checked and not fired, reaffirmation boundary preserved, the ambition converted into a classified three-part human decision bundle with an executor-safe alternative fork named for Stage 12.
4. **DQ-005 closed rather than artificially escalated.** With authority explicitly granted, both co-owners concurring, and no evidence of a competing commercial need, closing it as an implementation-specification is the correct anti-gate-inflation outcome.
5. **Positioning constrained to artifacts.** The claims table maps one-to-one onto Stage 10 §3, and the overclaim table maps one-to-one onto RR-1/3/4/5, source-policy §5, and the measurement-framework prohibitions — no claim outruns its artifact.

---

## Required corrections

**None.** Two non-blocking observations, recorded for traceability (no file change required for closure):

1. **O3 phrasing precision** (`outputs/sequencing-economics.md` §1): O3 renders D-03-01 condition 12 as "sequenced/staffed separately from AI-capability work." Condition 12 verbatim is "C1 and C2 remain classified as deterministic platform foundations, not agent capabilities." The "sequenced/staffed separately" operationalisation is inherited from this stage's own CONTEXT (which the executor was bound to consume) and is direction-preserving — it is consistent with Stage 02's finding language ("scoped, staffed, and reviewed as" conventional backend engineering) and constrains rather than relaxes. Noted only so a future reader tracing O3 to the decision prompt is not surprised by the paraphrase.
2. **Competitive framing in `positioning-and-claims.md` §4**: the asymmetry paragraph ("Competitors (manual bureaus, or AI products without assurance discipline) can say 'AI-powered' louder; none can say…") is definitionally bounded by its own parenthetical — a product without assurance artifacts cannot show them — and is framing for Stage 12, not a recorded finding. But no competitive-landscape source is registered (EG-005 covers demand, not competitor capabilities). Stage 12 should keep the competitor characterisation conditional/definitional rather than treating it as a verified market fact. Non-blocking; the document's §5 evidence constraint already points the right way.

---

## Decision classification (per CRITIC.md taxonomy)

| Item | Classification | Assessment |
|---|---|---|
| DQ-005 (CORRECTION UI exposure) | **implementation-specification** — closed | Correctly closed under explicitly granted joint authority; both co-owners concur; no product/risk residue |
| DQ-006 (Tier-1 source allowlist) | **blocking-human-decision** at C11 build authorisation; non-blocking for programme advancement | Correctly forwarded with logistics (professional engagement path); does not block Stage 11 closure or Stage 12 opening |
| DQ-007 (+ MFA hard-gate, decided together) | **blocking-human-decision** at C12 build authorisation; non-blocking now | Correctly packaged into the Stage 13 decision pack; the proposer≠approver → multi-operator-promotion consequence is properly surfaced |
| DQ-008 (retention legal basis) | **blocking-human-decision** only for retention-enforcing mechanisms; non-blocking now | Correctly bundled with DQ-006's engagement; interim floor preserved |
| Multi-tenant SaaS (F-11-01 bundle) | **blocking-human-decision** *if and only if* the SaaS trajectory is pursued | Correctly forwarded as a three-part bundle with the executor-safe fork named; does not block closure — the stage proposed nothing requiring it |
| Multi-operator workspaces | **non-blocking-forwarded-decision** (later-increment with named revisit triggers) | Correct — no forcing function exists; conditional promotion by DQ-007 is properly flagged |
| Area-15 operational reporting | **not-a-decision** today (later-increment, prerequisite named) | Correct — no evidence supports electing it over sequenced work; Stage 04's referral is discharged with reasoning |
| C15 email | **not-a-decision** (reconfirmed prior sequencing, no new fact) | Correct — reconfirmation, not re-litigation |
| EG-004 (next-onboarding timing) | **evidence-gap** (type-5, only Michael can supply) | Correctly queued; W2 dependency accurately stated |
| EG-005 (demand/willingness-to-pay) | **evidence-gap** (type-5 or registered external source) | Correctly queued; blocks external claims/SaaS decision, not the programme |
| FULL_RUN dead-option removal | **implementation-specification**, outside programme write authority | Correctly carried as a handoff item, not executed |

No artificial approval gates were created; the one closable item was closed. No material decision was made without authority — `decisions.md` correctly records zero human decisions made this stage, and I found none hidden in the outputs.

---

## Evidence-quality assessment

- **F-11-01**: meets the standard. All three schema fields populated; evidence is a same-day live read with verbatim excerpts duplicated into `evidence/` (correct treatment for out-of-repo files); cross-checked by this critic against the source files — accurate. Severity Medium is justified inline and proportionate (planning risk, no current harm).
- **F-11-02**: meets the standard for an absence finding. The sweep is dated, its scope is enumerated (S-01–S-10, all stage decision logs, HUMAN-DECISIONS), and this critic's independent grep sweep reproduced the zero-hit result. Severity Low with an escalation condition is right.
- **Outputs**: every load-bearing constraint, cost, and claim I traced (10+ of the O/W/cost rows, all four claimable properties, all nine overclaim rows, the DQ-005/RR-1 dispositions) resolves accurately to its cited source. No overclaiming found; several places (value map §3, positioning §5, stage-12 handoff §5) actively under-claim, which is the correct direction for this stage.
- **Source register**: S-10 correctly registered with the re-read basis and the type-4-not-type-5 caveat; the Stage 11 note correctly states no new external sources.

## Consistency assessment

- CONTEXT Q1–Q8 are each answered by a named output; completion criteria are met (business facts sourced/logged/gapped; DQ-005 dispositioned; handoffs complete; decisions classified; EG items queued).
- Stage-12 and Stage-13 handoffs are faithful compressions of the underlying outputs — I found no claim in either handoff that is not in (or stronger than) its source document; the SaaS fork, DQ-007 promotion consequence, and W2 fragility are carried forward intact.
- `decision-queue.md`, `review-state.md`, `state.md`, `CONTEXT.md` status, `findings.md`, and `decisions.md` are mutually consistent and consistent with the actual outputs.
- Binding decisions (D-02-01..04, D-03-01 + conditions, D-04-01, DEC-10-16, gate registers, measurement-framework prohibitions) are preserved everywhere; nothing is re-litigated or weakened.
- Writes stayed inside `docs/programmes/agentic-architecture-review/` (all 15 files in `e847160`); working tree clean; no production or unrelated changes.

---

## Advancement recommendation

**Close Stage 11 and open Stage 12 (Target Direction) automatically per `RUNBOOK.md`** — the critic verdict is PASS and no blocking human decision remains for closure. Items that must travel with the advancement (all already queued/handed off, listed for controller confirmation):

1. DQ-006/007/008 remain forwarded with their logistics; DQ-007 belongs in the Stage 13 decision pack.
2. EG-004 should be put to Michael early — it is the single scheduling fact the unrecoverable W2 window hinges on, and it costs one question.
3. Stage 12 must state the SaaS fork explicitly ("single-bureau excellence, SaaS-ready posture" vs "active SaaS trajectory") and treat the latter as requiring the human decision bundle — this is already in the Stage 12 handoff §3 and must not be softened.
4. The two non-blocking observations above require no action but should be visible to the Stage 12 executor.
